Advertisement

Related Videos

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

The Interventional Pharmacoeconomic Toolbox Panel Discussion

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Dec
19
Today In Oncology
CD123-Targeting ADC Shows Activity in AML and BPDCN
Data Published on Incidence of Immune Checkpoint Inhibitor-Associated ITP
Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC
Neoadjuvant SABR Improves Outcomes in Patients With RCC and IVC Tumor Thrombus
Lymphocyte Kinetics After CAR T Infusion Predict Survival Outcomes in Non-Hodgkin Lymphoma
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo